Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Institutional Ownership: 0.30% (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600381 Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
64 GF Score
Price ¥4.91
GF Value ¥5.94
Valuation Modestly Undervalued
View Full Analysis

What is Qinghai Spring Medicinal Resources Technology Co Institutional Ownership?

Qinghai Spring Medicinal Resources Technology Co SHSE:600381 +9.35% 64 Institutional Ownership is 0.30% as of Aug. 20, 2026. GuruFocus rates SHSE:600381 with a GF Score™ of 64/100 and a GF Value™ of ¥5.94 (Modestly Undervalued).

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Qinghai Spring Medicinal Resources Technology Co's institutional ownership is 0.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Qinghai Spring Medicinal Resources Technology Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Qinghai Spring Medicinal Resources Technology Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Qinghai Spring Medicinal Resources Technology Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qinghai Spring Medicinal Resources Technology Co Institutional Ownership Chart

Qinghai Spring Medicinal Resources Technology Co Historical Data

The historical data trend for Qinghai Spring Medicinal Resources Technology Co can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.09 0.17 0.17 0.19 0.40 0.40 0.40 0.43 0.43 0.30
SHSE:600381
64GF Score
Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qinghai Spring Medicinal Resources Technology Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.30% mean?
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) has a Institutional Ownership of 0.30% as of Aug. 20, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors.
Is Qinghai Spring Medicinal Resources Technology Co's Institutional Ownership too high?
Qinghai Spring Medicinal Resources Technology Co's current Institutional Ownership is 0.30%. Overall, Qinghai Spring Medicinal Resources Technology Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qinghai Spring Medicinal Resources Technology Co's Institutional Ownership compare to ZTS?
Qinghai Spring Medicinal Resources Technology Co's Institutional Ownership of 0.30% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. Qinghai Spring Medicinal Resources Technology Co's current Institutional Ownership is 0.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qinghai Spring Medicinal Resources Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.94, compared to a current price of ¥4.91 — trading 17.3% below its estimated fair value. The current Institutional Ownership is 0.30%. Qinghai Spring Medicinal Resources Technology Co's overall GF Score™ is 64/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Qinghai Spring Medicinal Resources Technology Co (SHSE:600381), the current Institutional Ownership is 0.30% as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?

Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued. The current stock price of ¥4.91 is trading 17.3% below its estimated GF Value™ of ¥5.94. GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600381:

  • Institutional Ownership: 0.30%
  • GF Value™: ¥5.94 vs. price of ¥4.91 (17.3% below fair value)
  • GF Score™: 64/100

No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qinghai Spring Medicinal Resources Technology Co Business Description

Address East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
64GF Score

Get the complete analysis for SHSE:600381

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.91
Price
¥5.94
GF Value